VEGF, Bevacizumab, Rabbit Antibody
R-2095-200
200 µL
Brand
biosensis
Description
ZZZZ_Status (Active, Disc) : Active
AA_Supplier Name : Biosensis
Alternative_Name (Other Names) :
ascular Endothelial Growth Factor; VEGF-A; VEGFA; Vascular Permeability Factor; VPF
Antibody_Isotype
(Antibody only) : IgGkappa
Application_Details :
This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
Background_Info :
Clone_Name
(AB only, monoclonals) : Bevacizumab
Datasheet_Link :
Description (Long Description) :
NOT FOR THERAPEUTIC USE – This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
Expiry_Date :
12 months after purchase if unopened.
Format (Form) :
Liquid, PBS with 0.02% Proclin 300.
Immunogen (Antigen) :Recombinant human VEGF.
Kit_Components :
MSDS (File name) :
Application
BlockELISAfcIPWB
Reactivity
Human